Improving Pneumococcus Vaccination Rates Among Patients With Cancer: An ASCO/CDC/CMSS-Sponsored Quality Improvement Project.
BACKGROUND Invasive pneumococcal disease poses a substantial danger to patients with cancer, who experience higher rates of infection, antimicrobial resistance, morbidity, and mortality. Pneumococcal vaccination reduces both cases of pneumonia and hospitalizations in this population. The Advisory Committee on Immunizat...